{"id":"W2922462803","doi":"10.1186/s13195-019-0467-2","title":"Evaluation of the efficacy, safety and tolerability of orally administered BI 409306, a novel phosphodiesterase type 9 inhibitor, in two randomised controlled phase II studies in patients with prodromal and mild Alzheimer’s disease","year":2019,"lang":"en","type":"article","venue":"Alzheimer s Research & Therapy","topic":"Phosphodiesterase function and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":52,"is_retracted":false,"has_abstract":true,"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"Cilag; Merck Sharp and Dohme; Novartis Pharma; Merz Pharmaceuticals; AstraZeneca; Eli Lilly and Company; Boehringer Ingelheim","keywords":"Tolerability; Medicine; Clinical Dementia Rating; Internal medicine; Clinical endpoint; Adverse effect; Placebo; Dementia; Clinical trial; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00250141,0.0001755211,0.0004288454,0.0001016665,0.00008549113,0.00001287652,0.0001131266,0.00005970009,0.00001350722],"category_scores_gemma":[0.0003576975,0.0001083084,0.00005727548,0.000263363,0.0004149539,0.00002064465,0.0001308817,0.0001297357,2.558845e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002300769,"about_ca_system_score_gemma":0.0003469545,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005455345,"about_ca_topic_score_gemma":0.0001381042,"domain_scores_codex":[0.9975069,0.0007550946,0.0004781155,0.0003960699,0.0006479513,0.000215842],"domain_scores_gemma":[0.9982516,0.0001623498,0.0001765748,0.0004015334,0.0009317896,0.00007620489],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.5664451,0.005359508,0.2921085,0.00006633584,0.00246491,0.00000109015,0.002899097,0.0004983609,0.09742329,0.00002417515,0.00006377748,0.03264586],"study_design_scores_gemma":[0.4305993,0.004642409,0.5138961,0.0002122439,0.000295375,6.85807e-7,0.0002319468,0.001298673,0.04828273,0.00004602877,0.0002299241,0.0002646158],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9808602,0.01448455,0.000001649645,0.0001631787,0.000099834,0.004344498,0.00002099899,0.000002700271,0.0000224192],"genre_scores_gemma":[0.9992998,0.0004268104,0.00003250702,0.00004029017,0.00001862432,0.0001086276,0.00003966067,0.00001504082,0.00001865144],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2217876,"threshold_uncertainty_score":0.441669,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1071811292687882,"score_gpt":0.4065201067674525,"score_spread":0.2993389774986643,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}